Publication
Generative AI: A global guide to key IP considerations
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Healthcare Regulation 2024
Getting the Deal Through, Lexology
Authors:
United States | Publication | 十一月 2023
Healthcare in America is big business. With annual expenditures in 2021 topping US$4.5 trillion, healthcare spending consumes 18.3 percent of the US gross domestic product. More than half of personal healthcare expenditures in the US are subsidized financially by the public sector, which makes government a key policy actor.
Susan Feigin Harris, Elise LeGros, Kathleen Rubinstein (Houston), Jeff Wurzburg (San Antonio/Washington, DC) and David Aplington (St. Louis), with Stacey Murphy (St. Louis), Mark Faccenda (Washington, DC), Denise Webb Glass, Jennifer Ann McDaniel (Dallas), Susan Linda Ross and Gerald A. Stein (New York) address a multitude of laws and regulations governing the US healthcare industry in their Lexology article, "Getting the Deal Through: Healthcare Regulation 2024."
Co-Head of Healthcare, United States
Email
susan.harris@nortonrosefulbright.com
Co-Head of Healthcare, United States Partner-in-Charge, Denver and St. Louis
Email
stacey.murphy@nortonrosefulbright.com
Office Administrative Partner, Dallas
Email
denise.glass@nortonrosefulbright.com
Senior Counsel
Email
jennifer.mcdaniel@nortonrosefulbright.com
Senior Counsel
Email
susan.ross@nortonrosefulbright.com
Senior Analyst, Health Care
Email
kathleen.rubinstein@nortonrosefulbright.com
Recent publications
Publication
NRF Director of Strategic Innovation & Design named Innovation leader of the year at the ILTA 2024 awards
We are delighted to announce that Al Hounsell, Director of Strategic Innovation & Legal Design based in our Toronto office, has been named 'Innovative Leader of the Year' at the International Legal Technology Association (ILTA) Awards.
Publication
TMT M&A trends: Road to recovery as sector looks to exploit technology deal drivers
After a lacklustre finish to 2022 when compared to the vintage year for M&A that was 2021, dealmakers expected 2023 to see the market continue to cool in most sectors, in response to the economic headwinds of rising inflation (with its corresponding impact on financing costs), declining market valuations, tightening regulatory scrutiny and increasing geopolitical tensions.
Subscribe and stay up to date with the latest legal news, information and events . . .